Rush University is a clinical research site located in Chicago, Illinois, United States 60612.
Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
Rush University has participated in 99 clinical trials with 32 currently active.
Therapeutic areas: Arteriovenous Fistula, Leukemia, Myeloid, Acute, Depressive Disorder.
Sponsors: C. R. Bard, Delta-Fly Pharma, Inc., MYnd Analytics.
Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rush University has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rush University has 99 clinical trials on record, with 32 currently active. Their work covers Arteriovenous Fistula, Leukemia, Myeloid, Acute, Depressive Disorder.
Rush University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.